A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1-Reference-Cited by-同舟云学术

A RANDOMIZED PROSPECTIVE CONTROLLED TRIAL OF ORAL ACYCLOVIR VERSUS ORAL GANCICLOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN HIGH-RISK KIDNEY TRANSPLANT RECIPIENTS1

Published:1998-12 Issue:12 Volume:66 Page:1682-1688
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Flechner Stuart M.,Avery Robin K.,Fisher Rosemaree,Mastroianni Barbara A.,Papajcik Doreen A.,O'Malley Kiaran J.,Goormastic Marlene,Goldfarb David A.,Modlin Charles S.,Novick Andrew C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference37 articles.

1. CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS

2. Impact of Cytomegalovirus Infection on Organ Transplant Recipients

3. THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTS

4. Symptomatic Cytomegalovirus Infection as a Significant Risk Factor for Major Infections After Cardiac Transplantation

5. The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18

2. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients;Cochrane Database of Systematic Reviews;2024-05-03

3. Efficacy and Safety of Antiviral Agents in Preventing Allograft Rejection Following CMV Prophylaxis in High-Risk Kidney Transplantation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials;Frontiers in Cellular and Infection Microbiology;2022-04-01

4. Are We Aware of the Neurological Manifestations of Cytomegalovirus Infection in Immunocompetent Individuals?;The Neurologist;2022-03-18

5. Effectiveness of Prophylactic Human Cytomegalovirus Hyperimmunoglobulin in Preventing Cytomegalovirus Infection following Transplantation: A Systematic Review and Meta-Analysis;Life;2022-03-02